Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 4
1985 2
1987 1
1988 3
1990 1
1992 2
1993 1
1998 3
2002 2
2003 4
2005 3
2006 3
2007 3
2008 9
2009 4
2010 5
2011 2
2012 2
2013 2
2014 2
2015 1
2016 3
2017 2
2018 3
2019 3
2020 4
2021 7
2022 4
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.
Howe AYM, Rodrigo C, Cunningham EB, Douglas MW, Dietz J, Grebely J, Popping S, Sfalcin JA, Parczewski M, Sarrazin C, de Salazar A, Fuentes A, Sayan M, Quer J, Kjellin M, Kileng H, Mor O, Lennerstrand J, Fourati S, Di Maio VC, Chulanov V, Pawlotsky JM, Harrigan PR, Ceccherini-Silberstein F, Garcia F; SHARED Collaborators. Howe AYM, et al. JHEP Rep. 2022 Feb 24;4(5):100462. doi: 10.1016/j.jhepr.2022.100462. eCollection 2022 May. JHEP Rep. 2022. PMID: 35434589 Free PMC article.
Survival of Patient With Hemorrhagic Meningitis Associated With Inhalation Anthrax.
Lombarte Espinosa E, Villuendas Usón MC, Arribas García J, Jado García I, Huarte Lacunza R, Zárate Chug P, Claraco Vega LM, Jesús Santed Andrés M, Ríos MJ, Cook R, Simard JM, Boyer AE, Rezusta A. Lombarte Espinosa E, et al. Among authors: rios mj. Clin Infect Dis. 2022 Oct 17;75(Suppl 3):S364-S372. doi: 10.1093/cid/ciac531. Clin Infect Dis. 2022. PMID: 36251557
Integrase inhibitors in children and adolescents: clinical use and resistance.
Torres-Fernandez D, Jiménez de Ory S, Fortuny C, Sainz T, Falcón D, Bernal E, Jiménez MC, Vilasaró MN, Epalza C, Navarro M, Ramos JT, Holguín Á, Prieto L; CoRIS and CoRISpe Spanish National Cohorts, CoRISpe and CoRISpe-FARO Cohort Working Group. Torres-Fernandez D, et al. J Antimicrob Chemother. 2022 Sep 30;77(10):2784-2792. doi: 10.1093/jac/dkac259. J Antimicrob Chemother. 2022. PMID: 35971971
Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy.
Tarancon-Diez L, Carrasco I, Jiménez de Ory S, Berzosa Sánchez A, Hernanz-Lobo A, Montero-Alonso M, Laguno M, Bernardino JI, López-Cortés L, Aldamiz-Echevarría T, Collado P, Bisbal O, Samperiz G, Gavilán C, Ríos MJ, Ibarra S, Navarro ML, Muñoz-Fernández MÁ. Tarancon-Diez L, et al. Among authors: rios mj. Biomed Pharmacother. 2023 Jun;162:114587. doi: 10.1016/j.biopha.2023.114587. Epub 2023 Mar 30. Biomed Pharmacother. 2023. PMID: 37003032 Free article.
High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use.
Gonzalez-Serna A, Macias J, Corma-Gomez A, Tellez F, Cucurull J, Real LM, Granados R, Rivero-Juarez A, Hernandez-Quero J, Merino D, Palacios R, Rios MJ, Collado A, Pineda JA. Gonzalez-Serna A, et al. Among authors: rios mj. J Infect. 2022 Sep;85(3):322-326. doi: 10.1016/j.jinf.2022.06.005. Epub 2022 Jun 11. J Infect. 2022. PMID: 35700867
The cadherin-catenin complex in nasopharyngeal carcinoma.
Galera-Ruiz H, Ríos MJ, González-Cámpora R, de Miguel M, Carmona MI, Moreno AM, Galera-Davidson H. Galera-Ruiz H, et al. Among authors: rios mj. Eur Arch Otorhinolaryngol. 2011 Sep;268(9):1335-41. doi: 10.1007/s00405-010-1464-z. Epub 2011 Jan 15. Eur Arch Otorhinolaryngol. 2011. PMID: 21240516 Free PMC article.
Adjuvant docetaxel for high-risk, node-negative breast cancer.
Martín M, Seguí MA, Antón A, Ruiz A, Ramos M, Adrover E, Aranda I, Rodríguez-Lescure A, Grosse R, Calvo L, Barnadas A, Isla D, Martinez del Prado P, Ruiz Borrego M, Zaluski J, Arcusa A, Muñoz M, López Vega JM, Mel JR, Munarriz B, Llorca C, Jara C, Alba E, Florián J, Li J, López García-Asenjo JA, Sáez A, Rios MJ, Almenar S, Peiró G, Lluch A; GEICAM 9805 Investigators. Martín M, et al. Among authors: rios mj. N Engl J Med. 2010 Dec 2;363(23):2200-10. doi: 10.1056/NEJMoa0910320. N Engl J Med. 2010. PMID: 21121833 Free article. Clinical Trial.
84 results